Mitogenic effect of angiotensin II on rat carotid arteries and type II or III mesenteric microvessels but not type I mesenteric microvessels is mediated by endogenous basic fibroblast growth factor

Circulation Research

Volumn 82, Issue 3, 1998, Pages 321-327

  Su, E J ^a,c   Lombardi, D M ^a   Wiener, J ^b   Daemen, M J A P ^c   Reidy, M A ^a   Schwartz, S M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Box 357335 ^*

Author keywords

Angiotensin II; Basic fibroblast growth factor; Rat; Smooth muscle cell

Indexed keywords

ANGIOTENSIN; ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; BROXURIDINE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CAROTID ARTERY; CELL DIVISION; CONTROLLED STUDY; DNA REPLICATION; HISTOCHEMISTRY; MACROPHAGE; MALE; MESENTERY BLOOD VESSEL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

EID: 0032559661     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.3.321     Document Type: Article

References (48)

1. Daemen MJAP, Lombardi DM, Bosman FT, Schwanz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured arterial wall. Circ Res. 1991;68:450-456.
2. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun. 1993;191:1081-1088.
3. 1-Adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res. 1992;70:1122-1127.
4. Berk BC, Rao GN. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J Cell Physiol. 1993;154:368-380.
5. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells: mitogenic responses to angiotensin II, Circ Res. 1992;71: 1143-1152.
6. Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, jMolloy CJ, Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol. 1994;8:148-158.
7. Prescott MF, Webb RL, Reidy MA. Angiotensin-converting enzyme inhibitor versus angiotensin II. AT1 receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 1991;139:1291-1296.
8. deBlois D, Viswanathan M, Su JE, Clowes AW, Saavedra JM, Schwartz SM. Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery: role of ATI receptor expression. Arteriosder Thromb Vasc Biol. 1996;16:1130-1137.
9. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68: 106-113.
10. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
11. Nguyen HC, Steinberg BM, LeBoutillier M, Baumann FG, Rifkin DB, Grossi EA, Galloway AC. Suppression of neoimimal lesions after vascular injury: a role for polyclonal anti-basic fibroblast growth factor antibody. Surgery. 1994;116:456-461.
12. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
13. Russo C, Callegaro L, Lanza E, Ferrone S. Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Methods. 1983;65: 269-271.
14. Koyama H, Reidy MA. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ Res. 1997;80:408-417.
15. Goto M, Matsuno K, Yamaguchi Y, Ezaki T, Ogawa M. Proliferation kinetics of macrophage subpopulations in a rat experimental pancreatitis model. Arch Histol Cytol. 1993;56:75-82.
16. Dijksrra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985;54:589-599.
17. Wiener J, Lombardi DM, Su EJ, Schwartz SM. Immunohistochemical and molecular characterization of the differential response of the rat mesenteric microvasculature to angiotensin II infusion. J Vase Res. 1996;33:195-208.
18. Ali S, Becker MW, Davis MG, Dorn GW. Dissociation of vasoconstrictorstimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells: relevant roles of protein kinase C. Circ Res. 1994;75:836-843.
19. Koibuchi Y, Lee WS, Gibbons GH, Pratt RE. Role of transforming growth factor-β1 in the cellular growth response to angiotensin II. Hypertension. 1993;21:1046-1050.
20. Abraham JA, Mergia A. Whang JL, Tumolo A, FriedmanJ, Hjerrild KA, Gospodarowicz D, Fiddes JC. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science. 1986;233:545-548.
21. Florkiewicz RZ, Shibata F, Barankiewicz T, Baird A, Gonzalez AM, Florkiewicz E, Shah N. Differential nuclear and cell surface localization. Growth Factors. 1991;4:265-275.
22. McNiel PL, Muthukrishnan L, Warder E, D'Amore P. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol. 1989;109: 811-822.
23. Muthukrishnan L, Warder E, McNeil P. Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J Cell Physiol. 1991;148:1-16.
24. Kaye D, Pinetal D, Prasad S, Maki T, Berger HJ, McNeil PL, Smith TW. Kelly RA. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocyies to increased mechanical activity in vitro. J Clin Invest. 1996;97:281-291.
25. Wiener J, Giacomelli F. The cellular pathology of experimental hypertension: structure and permeability of the mesenteric vasculature in angiotensin-induced hypertension. Am J Pathol. 1973;72:221-240.
26. Goldby FS, Beilin LJ. Relationship between arterial pressure and the permeability of arterioles to carbon particles in acute hypertension in the rat. Cardiovasc Res. 1972;6:384-390.
27. Giese J. Renin, angiotensin and hypertensive vascular damage: a review, Am J Med. 1973;55:315-331.
28. Jackson A, Friedman S, Zhan X, Engleka KA, Forough R, Maciag T. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sei U S A. 1992;89:10691-10695.
29. Jackson A, Tarantini F, Gamble S, Friedman S, Maciag T. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J Biol Client. 1995;270:33-36.
30. Florkiewicz RZ, Majack RA, Buechler RD, Florkiewicz E. Quantitative export of FGF-2 occurs through an alternative, energy-dependent, nonER/Golgi pathway. J Cell Physiol. 1995;162:388-399.
31. Folkmanj. Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol. 1988;130:393-400.
32. MoscateUi D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells, J Cell Physiol. 1987;131:123-130.
33. Moscatelli D. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol. 1988;107:753-759.
34. Gonzalez A-M, Buscaglia M, Ong M, Barid A. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol. 1990:110:753-765.
35. Sakesela O, Moscatelli D, Sommer A, Rifkin DB. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol. 1988:107:743-751.
36. Vigny M, Ollier-Hartmann MP, Lavigne M, Fayein N, Jeanny JC, Laurent M, Courtois Y. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor. J Cell Physiol. 1988;137:321-327.
37. 1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall: modulation of responsiveness after vascular injury. Arterioscler Thromb Vasc Biol. 1996;16:1122-1129.
38. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997-1101.
39. Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD. Ohlstein EH. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty: protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res. 1994;75:190-197.
40. Marks DS, Vita JA, FoltsJD, Keaney JF. Welch GN, Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduce nitric oxide. J Clin Imvst. 1995;96: 2630-2638.
41. Groves PH, Banning AP, Penny WJ, Newby AC, Cheadle HA, Lewis MJ. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Canliai'iuc Res. 1995:30:87-96.
42. Wang J, Wang S, Lu Y, Weng Y. Gown A. GM-CSF and M-CSF expression is associated with macrophage proliferation in progressing and regressing rabbit atheromatous lesions. Exp Mol Palhol. 1994;61: 109-118.
43. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary aneries. Proc Natl Acad Sci U S A. 1990;87:4600-4604.
44. Rosenfeld ME, Yla-Herttuala S, Lipton BA, Ord VA, Witztum JL, Steinberg D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol. 1992;140: 291-300.
45. Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int. 1995;48:753-760.
46. Cavaillon JM. Cytokines and macrophages. Biomed Pharmamther. 1994:48: 445-453.
47. Rappolee DA, Werb Z. Macrophage-derived growth factors. Cim Top Microbiol Immunol. 1992;181:87-140.
48. Griffin S, Brown W, MacPherson F, McGrathJ, Wilson V, Korsgaard N, Mulvany M, Lever A. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991:17:626-635.